MFDS
- Status: likely_approved
🇰🇷 Elelyso in South Korea
Elelyso (Taliglucerase Alfa) regulatory status in South Korea.
Marketing authorisation
Elelyso in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in South Korea
Frequently asked questions
Is Elelyso approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Elelyso in South Korea?
Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.